Reza Hosseinpour1,2, Mohammad Javad Yavari Barhaghtalab2. 1. Cancer institute, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran. 2. Department of General Surgery, Shahid Beheshti Hospital, Yasuj University of Medical Sciences, Yasuj, Iran.
Abstract
BACKGROUND: Five to ten percent of the patients with operable breast cancer develop a chest wall recurrence within 10 years following the mastectomy. One of the most distressing presentations of locally recurrent breast cancer is the appearance of cutaneous metastases. To the best of authors' knowledge, there is no study distinguishing skin metastasis from local recurrence, so the main aim of this report was to elucidate if these two features are important in the prognosis and management of the disease. Case Presentation. A 51-year-old woman referred to the breast clinic due to a painful mass in the left breast. The patient underwent the modified radical mastectomy (MRM) and left axillary lymph node dissection followed by 30 sessions of radiotherapy and 8 sessions of chemotherapy (T3N1M0, ER-, and HER2+). About 15 months after the surgery, she presented with redness and eruptive lesions over the mastectomy scar that increased in size within a three-month follow-up. CONCLUSION: Mastectomy is not an absolute cure in the treatment of an invasive breast cancer because almost always, there is a recurrence risk and possibility of metastasis. It is vital to differentiate between local recurrence and skin metastasis because it would alter the overall treatment decision, prognosis, and patient outcomes.
BACKGROUND: Five to ten percent of the patients with operable breast cancer develop a chest wall recurrence within 10 years following the mastectomy. One of the most distressing presentations of locally recurrent breast cancer is the appearance of cutaneous metastases. To the best of authors' knowledge, there is no study distinguishing skin metastasis from local recurrence, so the main aim of this report was to elucidate if these two features are important in the prognosis and management of the disease. Case Presentation. A 51-year-old woman referred to the breast clinic due to a painful mass in the left breast. The patient underwent the modified radical mastectomy (MRM) and left axillary lymph node dissection followed by 30 sessions of radiotherapy and 8 sessions of chemotherapy (T3N1M0, ER-, and HER2+). About 15 months after the surgery, she presented with redness and eruptive lesions over the mastectomy scar that increased in size within a three-month follow-up. CONCLUSION: Mastectomy is not an absolute cure in the treatment of an invasive breast cancer because almost always, there is a recurrence risk and possibility of metastasis. It is vital to differentiate between local recurrence and skin metastasis because it would alter the overall treatment decision, prognosis, and patient outcomes.
Authors: I Gage; S J Schnitt; A Recht; A Abner; S Come; L N Shulman; J M Monson; B Silver; J R Harris; J L Connolly Journal: J Clin Oncol Date: 1998-02 Impact factor: 44.544
Authors: A Recht; S J Schnitt; J L Connolly; M A Rose; B Silver; S Come; I C Henderson; S Slavin; J R Harris Journal: Int J Radiat Oncol Biol Phys Date: 1989-01 Impact factor: 7.038
Authors: Carlos Vargas; Larry Kestin; Nel Go; Daniel Krauss; Peter Chen; Neal Goldstein; Alvaro Martinez; Frank A Vicini Journal: Int J Radiat Oncol Biol Phys Date: 2005-07-11 Impact factor: 7.038
Authors: A L Abner; A Recht; T Eberlein; S Come; L Shulman; D Hayes; J L Connolly; S J Schnitt; B Silver; J R Harris Journal: J Clin Oncol Date: 1993-01 Impact factor: 44.544
Authors: Awrad Mohammed-Reda Nasralla; Mohammed Abdulirazzaq Al-Duhileb; Ali Jamal-Aldein Arini; Samir Sami Amr Journal: Case Rep Surg Date: 2017-08-10